Loading chat...

OK HB2807

Bill

Official Source

Status

Introduced

2/1/2016

Primary Sponsor

David Derby

Click for details

Origin

House of Representatives

2016 Regular Session

AI Summary

  • Excludes ioflupane I-123 from all schedules of controlled substances under Oklahoma's Uniform Controlled Dangerous Substances Act
  • Ioflupane I-123 is a diagnostic radiopharmaceutical used in brain imaging to help diagnose Parkinson's disease and related movement disorders
  • Amends Section 2-206 of Title 63, which defines Schedule II controlled substances
  • Effective date of November 1, 2016

Legislative Description

Public health and safety; excluding certain substance from Schedule II; effective date.

Last Action

Second Reading referred to Rules

2/2/2016

Committee Referrals

Rules2/2/2016

Full Bill Text

No bill text available